FDA clears Saluda Medical's CAP24 paddle lead for spinal cord stimulation
Tweet Send to a Friend
Saluda Medical (ASX: SLD) announced that the U.S. Food and Drug Administration has approved its CAP24 surgical paddle lead, allowing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


